Compare Equinix Inc (EQIX) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs Smith & Nephew plc — how do they compare? Equinix Inc trades at $1,018 (market cap $99.77B), while Smith & Nephew plc trades at $27.22 (market cap $11.10B). The key difference: Equinix Inc is far larger — about 9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and Smith & Nephew plc for 120 Days on average.
| EQIX | SNN | |
|---|---|---|
Market Cap | $99.77B | $11.10B |
Volume | 480,425 | 1,051,703 |
Sector | Real Estate | Health |
52-Week High | $1.12K | $37.17 |
52-Week Low | $726.09 | $26.42 |
Typical Hold Time | 110 Days | 120 Days |
Enterprise Value | $120.90B | $14.13B |
Dividend Yield | 2.04% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $1,031.77, down 1.49% on the day, amid a bullish technical setup with support at $1,025 and resistance at $1,042. The company reported revenue growth to $9.22B in 2025 and a net income margin of 15.63%, though it missed EPS estimates in two of the last three quarters. Recent news highlights strong AI-driven demand for data centers, with Equinix planning $5B-$7B in annual investments to expand capacity.
Outlook remains positive given analyst consensus of a $1,250 price target and 75% buy ratings, but risks include high valuation multiples (P/E 65.07) and rising debt-to-asset ratio (47.13% in 2025). The stock offers growth exposure to AI infrastructure trends, yet investors should weigh capex intensity against earnings sustainability.
Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
